Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
34.3 DKK | +0.29% |
|
-3.53% | -0.69% |
06-26 | Otsuka and Lundbeck's PTSD Treatment Moves Forward as FDA Accepts New Drug Application | MT |
06-25 | US FDA Accepts Lundbeck, Otsuka's New Drug Application for PTSD Combo Treatment | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.71% | 75.74B | |
-4.57% | 23.24B | |
+17.81% | 8.76B | |
-31.67% | 6.69B | |
+3.99% | 4.22B | |
-3.94% | 3.99B | |
+14.24% | 3.39B | |
+10.59% | 3.23B | |
-14.43% | 3.13B |
- Stock Market
- Equities
- HLUN B Stock
- LUN Stock
- News Lundbeck
- Transcript : H. Lundbeck A/S Presents at 35th Annual JP Morgan Healthcare Conference, Jan-09-2017 04